Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 14,042 | 9,801 | 9,136 | 8,446 | 7,140 |
| Cost of Goods | 9,522 | 9,256 | 9,438 | 7,243 | 4,333 |
| Gross Profit | 4,520 | 545 | -302 | 1,203 | 2,807 |
| Operating Expenses | 28,702 | 40,258 | 48,669 | 33,165 | 26,978 |
| Operating Income | -23,660 | -39,457 | -48,533 | -31,719 | -23,838 |
| Interest Expense | 7,302 | 4,363 | 2,907 | 6,056 | 2,466 |
| Other Income | -109 | 92 | -219 | 6,533 | -12,490 |
| Pre-tax Income | -31,071 | -43,728 | -51,659 | -31,242 | -38,794 |
| Net Income Continuous | -31,071 | -43,728 | -51,659 | -31,242 | -38,794 |
| Net Income | $-31,071 | $-43,728 | $-51,659 | $-31,242 | $-38,794 |
| EPS Basic Total Ops | -1.26 | -1.79 | -2.32 | -3.74 | -32.48 |
| EPS Basic Continuous Ops | -1.26 | -1.79 | -2.32 | -3.58 | -30.86 |
| EPS Diluted Total Ops | -1.26 | -1.79 | -2.32 | -4.25 | -32.48 |
| EPS Diluted Continuous Ops | -1.26 | -1.79 | -2.32 | -3.51 | -30.86 |
| EPS Diluted Before Non-Recurring Items | -1.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-21,425 | $-35,947 | $-45,942 | $-30,725 | $-23,225 |